跳至主要内容
临床试验/NCT07411118
NCT07411118招募中不适用

Exposed Endoscopic Full Thickness Resection (EFTR) Versus Submucosal Tunnelling Endoscopic Resection (STER) for Small Gastric Gastrointestinal Stromal Tumor (GIST) - an International Double Blinded Randomized Controlled Trial

Chinese University of Hong Kong4 个研究点 分布在 4 个国家目标入组 136 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
136
试验地点
4
主要终点
Complete R0 resection

研究概览

简要总结

Endoscopic resection has been increasing utilized as the treatment for small size gastrointestinal stromal tumors (GIST), of which the best resection method has not been identified. We aim to compare the outcomes of endoscopic full thickness resection (EFTR) versus submucosal tunnelling endoscopic resection (STER) for clinical small gastric GIST. We hypothesize that EFTR could achieve better complete margin negative resection than STER without increase in adverse event.

This is an international multi-center double blinded randomized controlled trial involving four high volume centers from Hong Kong, mainland China, India and Japan. Adult patients with clinical 1.0-3.Scm gastric GIST undergoing endoscopic resection would be recruited.

Patients would be randomized to undergo EFTR (intervention) or STER (Control) by expert endoscopists under general anaesthesia according to well published methods.

详细描述

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumors in the GI tract, often located in the stomach. Based on the latest World Health Organization (WHO) classification, all GISTs are now considered as malignant tumors. Large size overtly aggressive GISTs are relatively rare, occurring only in up to 8 per million population. However, smaller sizes GIST in the stomach are relatively common, and was found in up to 20% of patients based on autopsy series.

Conventionally, localized GISTs are treated by surgical resection. Several guidelines recommended resection of all histologically confirmed GIST, while some suggested surveillance if the lesion is small <2cm in size. The principle of surgery for GIST is for en-bloc margin negative complete resection, while lymph node dissection is not required. As such, laparoscopic resection of gastric GIST has been advocated when technically feasible, demonstrating short term benefits in recovery than open surgery, with similar oncological outcomes.

With the technological advances of endoscopic surgery including endoscopic submucosal dissection (ESD) for early epithelial cancers and per-oral endoscopic myotomy (POEM), there was a rapid expansion in the indication of endoscopic surgery, in particular resection of subepithelial tumors (SET) in the gastrointestinal tract, in which a significant proportion are GISTs. Systematic review revealed a shorter procedure time and improved short-term recovery by endoscopic resection versus laparoscopic resection, without significant difference in complication and survival. With the favourable outcomes consistently reported in the literature regarding endoscopic resection of upper gastrointestinal GISTs, several endoscopy and oncology society guidelines are now recommending endoscopic resection as an option for smaller size GISTs in institutions with expertise on therapeutic endoscopy.

Submucosal tunneling endoscopic resection (STER) was first reported by Xu, et al in 2012. The concept of the procedure is to create a submucosal tunnel away from the tumor that arose from the musclaris propria layer while protecting the mucosa directly overlying the lesion, so that only mucosal closure of the tunnel entrance would be required after resection. The technique was first used on esophageal SET, where majority of them are benign leiomyoma. STER was then subsequently applied to other upper gastrointestinal tract lesions including the stomach. The merit of the technique mainly lies in the simplicity of closure of the mucosal incision, which only requires simple through-the-scope (TTS) clips. A schematic diagram of the STER procedure is shown in Figure 1.

Development of various techniques that allowed secure endoscopic water-tight closure of full thickness wall defect has led to increasing application of endoscopic full thickness resection (EFTR). As opposed to the STER procedure, the tumor would be directly resected without creation of a submucosal tunnel. This would create a full thickness defect that required complete closure to avoid gastrointestinal leakage and peritonitis. Various methods have been reported for closure, ranging from simple TTS clip closure, over-the-scope clip closure, clip endo-loop purse string technique, re-openable clip over-the-line method (ROLM), endoscopic suturing etc. With appropriate selection of closure method based on the morphology of the defect, secure closure could be achieved with minimal post-procedural morbidity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive adult patients age >=18 and <=75 with a clinical diagnosis of gastric GIST who opted for endoscopic resection would be screened for eligibility.
  • Inclusion Criteria:
  • Presence of gastric subepithelial tumor on diagnostic upper endoscopy, and
  • Diagnostic EUS and CT scan with intravenous contrast suspicious of GIST arising from muscularis propria layer, size with maximum diameter >=1.0cm and <= 3.5cm, and
  • Absence of high risk features, including irregular margins, invasion to surrounding organs, lesion hypervascularity, and
  • Endoscopic morphology and location deemed feasible with both EFTR and STER by an expert endoscopist, or
  • Histological confirmation of GIST through EUS guided fine needle biopsy (Optional, based on recommendation from guidelines)

排除标准

  • Patients with tumors deemed not suitable for endoscopic resection (Either EFTR or STER), due to unfavourable location, high risk morphology, or any other reasons.
  • Patients with multiple tumors.
  • Patients unable or unwilling to provide consent.
  • Previous esophageal or gastric surgery.
  • Patients with significant cardiorespiratory comorbidities which may limit their ability to undertake general anesthesia for the procedure, including ASA grade III or above.
  • Pregnant women or those planning pregnancy or breastfeeding women.
  • Uncorrectable coagulopathy defined by international normalized ratio (INR) > 1.5 or platelet count < 50000/µl.
  • Patients on double anti-platelet agents or anti-coagulation (Warfarin, heparin or other direct oral anticoagulants)

研究组 & 干预措施

Endoscopic full thickness resection (EFTR) Group

Experimental

Patients would be randomized to undergo EFTR by expert endoscopists under general anaesthesia according to well published methods.

干预措施: Endoscopic full thickness resection (EFTR) / Exposed non-tunneling EFTR (Procedure)

Submucosal Tunneling Endoscopic Resection (STER) Group

Active Comparator

Patients would be randomized to undergo STER by expert endoscopists under general anaesthesia according to well published methods.

干预措施: Submucosal Tunneling Endoscopic Resection (STER) / Exposed tunneling EFTR (Procedure)

结局指标

主要结局

Complete R0 resection

时间窗: 1 day

Complete R0 resection, defined as en-bloc complete endoscopic resection with intact tumor capsule and histological negative resection margins. Measure unit: % of lesions.

次要结局

  • Rate of Intra-procedural adverse events(1 day)
  • Rate of post-procedural adverse events(30 days)
  • Procedure time(1 day)
  • Crossover rate to EFTR in STER group(30 days)
  • Conversion rate to major surgery(30 days)
  • Recurrence rate(30 days)
  • Patient-reported VAS scores(Day 1, 3, 7, and 14 after procedure)
  • Endoscopist-rated procedural difficulty(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hon Chi Yip

Assistant Professor

Chinese University of Hong Kong

研究点 (4)

Loading locations...

相似试验